To further investigate the underlying mechanism of co-treatment therapy, we examined several major downstream signaling molecules of tyrosine kinases, including Stat1 and Stat3, in tumor tissues isolated at the end of the pharmacodynamic assay. Here, STAT1 is linked to neoplasm.